Rules tightened for human placenta drugs

The Korea Food and Drug Administration said on June 21 that it amended the Enforce Regulation of the Pharmaceutical Affairs Law to tighten controls over human placenta drugs in terms of its better safety and efficacy profiles.

Under the revised rules, human placenta drugs are subject to the categories of health registration items, along with other items such as new drugs, drugs whose safety...